A sharp selloff in crude kept stocks mostly in the red, though optimism ahead of Friday's jobs reports kept losses to a minimum on Thursday. Oil closed at a two-month low after a disappointing read on weekly inventories. Humana (HUM) shares tumbled their most in nearly four years on worries its planned purchase of Aetna (AET) won't pass regulatory muster. Officials from both companies will reportedly meet with the Department of Justice tomorrow to discuss antitrust issues. BioMarin Pharmaceuticals (BMRN) soared on speculation Roche (RHHBY) could pursue a takeover. Shares spiked around nine percent, though the reports are so far unconfirmed. First Solar (FSLR) tumbled after Deutsche Bank downgraded to HOLD from BUY. The firm said increased competition from Chinese suppliers is providing risk to margins, while company bookings growth has likely slowed. TheStreet's Keris Lahiff reports from Wall Street.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.